Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124401212 | 12440121 | 2 | F | 20150820 | 20160913 | 20160606 | 20160921 | EXP | US-AMGEN-USASL2015088197 | AMGEN | 67.00 | YR | E | F | Y | 121.54000 | KG | 20160921 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124401212 | 12440121 | 1 | PS | PROCRIT | ERYTHROPOIETIN | 1 | Subcutaneous | 10000 UNIT/ML, EVERY THREE WEEKS | 103234 | SOLUTION FOR INJECTION | |||||||||
| 124401212 | 12440121 | 2 | SS | PROCRIT | ERYTHROPOIETIN | 1 | 103234 | SOLUTION FOR INJECTION | |||||||||||
| 124401212 | 12440121 | 3 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 100 MG, (TAKE 1 TABLET TWICE DAILY 30 DAYS) | 0 | 100 | MG | TABLET | BID | ||||||
| 124401212 | 12440121 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, BID | 0 | 300 | MG | CAPSULE | BID | ||||||
| 124401212 | 12440121 | 5 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Oral | 5 MG, BID (2 CAPSULE BY MOUTH, 30 DAYS) | 0 | 5 | MG | CAPSULE | BID | ||||||
| 124401212 | 12440121 | 6 | C | IRON | IRON | 1 | Oral | 325 MG, TID | 0 | 325 | MG | TABLET | TID | ||||||
| 124401212 | 12440121 | 7 | C | ASPIR 81 | 2 | Oral | 81 MG, QD | 0 | 81 | MG | TABLET | QD | |||||||
| 124401212 | 12440121 | 8 | C | GLYBURIDE. | GLYBURIDE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | TABLET | BID | ||||||
| 124401212 | 12440121 | 9 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, TID (30 DAYS) | 0 | 25 | MG | TABLET | TID | ||||||
| 124401212 | 12440121 | 10 | C | PROVENTIL HFA | ALBUTEROL SULFATE | 1 | UNK (INHALATION) | 0 | |||||||||||
| 124401212 | 12440121 | 11 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 124401212 | 12440121 | 12 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 10 MG, BID (30 DAYS) | 0 | 10 | MG | TABLET | BID | ||||||
| 124401212 | 12440121 | 13 | C | METOLAZONE. | METOLAZONE | 1 | Oral | 2.5 MG, QW | 0 | 2.5 | MG | TABLET | |||||||
| 124401212 | 12440121 | 14 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 50 MCG, QD | 0 | 50 | UG | CAPSULE | QD | ||||||
| 124401212 | 12440121 | 15 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 10 MG, BID (30 DAYS) | 0 | 40 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124401212 | 12440121 | 1 | Anaemia |
| 124401212 | 12440121 | 2 | Chronic kidney disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124401212 | 12440121 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124401212 | 12440121 | Albuminuria | |
| 124401212 | 12440121 | Blood creatinine increased | |
| 124401212 | 12440121 | Blood glucose increased | |
| 124401212 | 12440121 | Blood triglycerides increased | |
| 124401212 | 12440121 | Blood uric acid increased | |
| 124401212 | 12440121 | Decreased appetite | |
| 124401212 | 12440121 | Diabetic nephropathy | |
| 124401212 | 12440121 | Essential hypertension | |
| 124401212 | 12440121 | Gout | |
| 124401212 | 12440121 | Haematocrit decreased | |
| 124401212 | 12440121 | Haemoglobin decreased | |
| 124401212 | 12440121 | Hyperparathyroidism secondary | |
| 124401212 | 12440121 | Iron binding capacity total decreased | |
| 124401212 | 12440121 | Mobility decreased | |
| 124401212 | 12440121 | Musculoskeletal pain | |
| 124401212 | 12440121 | Nephrogenic anaemia | |
| 124401212 | 12440121 | Oedema | |
| 124401212 | 12440121 | Osteoporosis | |
| 124401212 | 12440121 | Pain in extremity | |
| 124401212 | 12440121 | Proteinuria | |
| 124401212 | 12440121 | Sleep apnoea syndrome | |
| 124401212 | 12440121 | Type 2 diabetes mellitus | |
| 124401212 | 12440121 | Vitamin D deficiency | |
| 124401212 | 12440121 | Wheelchair user |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |